WorldMap

Our global network of employees and manufacturing facilities works around the clock to deliver products to patients worldwide.

Every hour there is a plane in the air, a ship on the seas or a truck on the road delivering Teva medicines to pharmacies and hospitals. Our ambition is that our patients get the right medicine where and when they need it.

 

Visit your local Teva website

Click here to view sites

Toggle Expand/ Collapse

North America

International Markets

Europe

North America

International Markets

Europe

north-america-map

Teva in North America

Teva is a leading generic medicine company in North America, where 1 of every 12 generic prescriptions in the US is filled with a Teva product. Teva also invests significant activity in innovative medicine development focused on neuroscience, immunology, and other disease areas.

Map of the Europe

Teva in Europe

With headquarters in The Netherlands, Teva Europe leads operations across more than 30 countries in the region; over 76 nationalities comprising a diverse and dynamic workforce. Teva Europe includes R&D, manufacturing and commercial offices. We market a range of innovative medicines, generic medicines, and consumer healthcare products. Teva is one of Europe’s biggest providers of tried-and-trusted quality generic medicines. Teva Europe estimates that we save some €8 billion each year from Europe’s healthcare budget by supplying cost-effective treatments.

international-markets-map

Teva in International Markets

Teva has a focused and effective commercial footprint in 25 international markets, including key Latin America countries, Russia and Eastern Europe, Israel, the Middle East, Africa, Asia-Pacific, China and Japan. With our professional, multi-cultural workforce, we provide a high-quality portfolio of specialty medicines, generics and biopharmaceuticals, active pharmaceutical ingredients (API) and over-the-counter products. Teva is already a leader in key international markets, and we continue working to strengthen our presence and expand treatment options for the patients who need them.